In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it. Prices (Fares, Fees and Rates), Inventions and Patents, Drugs (Pharmaceuticals), Health Insurance and Managed Care, Law and Legislation, Regulation and Deregulation of Industry, State Legislatures, Autoimmune Diseases, Insurance, Generic Brands and Products, Antitrust Laws and Competition Issues, Enbrel (Drug), Amgen Inc, Food and Drug Administration, Sandoz International GmbH, Biden, Joseph R Jr, Colorado Read More
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
